GastroEsophageal Cancer New Protocol: Atezolizumab and Trastuzumab with CapeOx for Periop Her2+ Gastric Cancer Ulas D. Bayraktar, MD 2025-05-04
Mesothelioma New Protocol: Atezolizumab with Carbo-Pem-Bev for Pleural Mesothelioma Ulas D. Bayraktar, MD 2025-05-04
Endocrine Cancer (Non-Thyroid) New Reference: Belzutifan for vHL Associated Tumors Ulas D. Bayraktar, MD 2025-05-04
Non-Small Cell Lung Cancer New Reference: Afatinib for NSCLC with Uncommon EGFR Mutations Ulas D. Bayraktar, MD 2025-04-22
Soft Tissue Sarcoma New Reference: Botensilimab / Balstilimab for Metastatic Sarcomas Ulas D. Bayraktar, MD 2025-04-22
Breast Cancer New Protocol: Metronomic Capecitabine with Aromatase Inhibitors in Metastatic Breast Cancer Ulas D. Bayraktar, MD 2025-04-22
Breast Cancer New Protocol: Eribulin with Trastuzumab-Pertuzumab in First-Line Breast Cancer Ulas D. Bayraktar, MD 2025-04-22
Non-Small Cell Lung Cancer New Indication: Nivolumab – Ipilimumab for Neoadjuvant NSCLC Ulas D. Bayraktar, MD 2025-04-22
Soft Tissue Sarcoma New Protocol: Regorafenib Maintenance for Sarcoma Ulas D. Bayraktar, MD 2025-04-22
Non-Small Cell Lung Cancer New Reference: Taletrectinib for ROS1-Positive NSCLC Ulas D. Bayraktar, MD 2025-04-22
